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Abstract
Background: Recent pathological studies have suggested that thalamic degeneration may
represent a site of non-dopaminergic degeneration in Parkinson's Disease (PD). Our objective was
to determine if changes in the thalami could be non-invasively detected in structural MRI images
obtained from subjects with Parkinson disease (PD), compared to age-matched controls.
Results: No significant differences in volume were detected in the thalami between eighteen
normal subjects and eighteen PD subjects groups. However significant (p < 0.03) shape differences
were detected between the Left vs. Right thalami in PD, between the left thalami in PD and
controls, and between the right thalami in PD and controls using a recently-developed, spherical
harmonic-based representation.
Conclusion: Systematic changes in thalamic shape can be non-invasively assessed in PD in vivo.
Shape changes, in addition to volume changes, may represent a new avenue to assess the progress
of neurodegenerative processes. Although not directly discernable at the resolution of standard
MRI, previous pathological studies would suggest that the shape changes detected in this study
represent degeneration in the centre median-parafascicular (CM-Pf) complex, an area known to
represent selective non-dopaminergic degeneration in PD.
Background
The thalamic changes seen in Parkinson Disease (PD)
may represent selective non-dopaminergic degeneration
[1], as there is selective neuronal loss in the centre
median-parafascicular (CM-Pf) complex in Parkinson's
disease [2], yet relative preservation of neurons in the lim-
bic (mediodorsal and anterior principal) thalamic nuclei.
Henderson et al. examined the thalamic intranuclear
nuclei in 10 normal controls and 9 patients with PD [3].
As expected, they found α-synuclein-positive Lewy bodies
in these nuclei in the thalamus, but they also found a sig-
nificant reduction (40–55%) in the total neuronal
number in the caudal intralaminar (CM-Pf) nuclei,
regions that receive glutaminergic innervation [3]. This
contrasted with the 70% loss of pigmented nigral neu-
rons. A factor analysis has demonstrated that the size of
neurons in the motor cortex is negatively correlated with
the size and number of neurons in its thalamic relay, the
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number of ventral anterior (VA) neurons and the pre-sup-
plementary motor area (SMA) [4].
Bacci et al. suggested that CM-Pf degeneration may par-
tially counteract the consequences of dopamine neuronal
loss, as thalamic and dopamine inputs have antagonistic
influence on neurotransmitter-related gene expression
[1]. Moreover, the CM-Pf degeneration may be a direct
consequence of nigrostriatal denervation, as depleting the
striatum of dopamine results in the remaining Pf neurons
being particularly hyperactive [5].
The normal role of the CM-Pf complex is incompletely
understood, although it is clearly related to basal ganglia
function [6]. The Pf nuclei receive input from the spinal
cord and project to the striatum [7]. These projections
may carry specific temporally-patterned inputs to striatal
targets [8]. While the CM-Pf complex has traditionally
been considered part of the reticulo-thalamo-cortical acti-
vating system, a recent proposal suggests that the CM-Pf
complex participates in sensory driven attentional proc-
esses, particularly unexpected events [9].
The advent of modern imaging techniques has allowed
the noninvasive in vivo assessment of brain structures,
such as the thalamus, in disease states. Thalamic morpho-
logical changes have been detected chronically after corti-
cal injury, such as middle cerebral artery (MCA) infarction
after 1 yr [10,11] and tumor resection after ~2 yrs [12].
The study by Hulshoff Pol [12] detected a 5% decrease in
ipsilateral thalamus and, interestingly, a 4.5% increase in
contralateral thalamic volume after unilateral tumor
resection, presumably on the basis of a compensatory
mechanism.
In PD and related disorders, some studies of structural
and functional imaging have detected thalamic changes.
Thalamic grey matter changes have been detected contral-
ateral to unilateral Parkinsonian resting tremor [13]. In
PD with dementia, the thalamus, in addition to the hip-
pocampus and anterior cingulate, represent the regions
most affected [14]. Functionally, there is a connection
between a major component in F-DOPA uptake in the
striatum and a component from fluoro-deoxy – glucose
(FDG), which had positive loadings in the thalamus and
the cerebellum [15].
Most morphological studies based on imaging involve a
number of steps manipulating the brain images. A typical
approach would be to warp ("spatially normalize") the
brain images to a common space [13]. Further smoothing
of the data (e.g. using an isotropic 12 mm Gaussian ker-
nel) to minimize the effects of misregistration between
different normalized brains may affect the ability to make
inferences about small, subcortical structures like the tha-
lamus. In fact this "Voxel Based Morphometry" approach
has thus been a controversial approach (e.g., see discus-
sions in [16] and [17]).
Recent approaches try to reduce errors due to misregistra-
tion by aligning the subjects at the region of interest (ROI)
level, as opposed to the whole brain level [18-20]. How-
ever, these approaches are designed to deal with a differ-
ent problem, namely that of summarizing fMRI activation
from several subjects. To quantify differences in morphol-
ogy, it would be necessary to examine the different trans-
formations required to warp each subject's ROIs to the
examplar ROI shape – a non-trivial task.
An alternative approach to warping brains to the same
space is to segment brain structures individually on
unmanipulated (i.e. unregistered and unwarped) brains
[21]. Because no registration of the brain images is done,
this requires summarizing the individual brain structures
in a way that they are invariant to positioning of the head
in the scanner. For example, simply estimating the vol-
ume of an ROI such as the thalamus has this property, as
it is invariant to the individual coordinate frame used. A
number of such invariants (e.g. spatial variance) have
been proposed to summarize the shape of brain structures
[22], or even characterize the distribution (texture) of acti-
vation maps in fMRI [23].
We have recently proposed a method based on spherical
harmonics (SPHARM) which provided a unique represen-
tation of brain structures, including regions with possible
topological disconnections, such as the lateral ventricles
[24]. In brief, the method involves first finding a spherical
shell which encompasses the entire ROI. Subsequent
smaller concentric shells are then derived and the intersec-
tion between the progressively smaller spherical shells
and the brain structure is computed (Figure 1). The results
from the intersections are then combined into a unique
feature vector containing approximately 100's or 1000's of
elements. This feature vector provides a unique represen-
tation of the shape which is independent of the spatial ori-
entation of the structure (see Methods).
We examined the thalami from 18 PD subjects and 18
age-matched controls. Using the above technique, we
found significant differences between the two groups in
the shape of the thalami, but not in the volume. This sug-
gests that significant thalamic changes can be assessed
noninvasively in PD, suitable for longitudinal studies.
Results
There were no significant differences in volume between
sides in either controls or PD subjects, nor between con-
trols and PD subjects in either the left or right thalamusPage 2 of 8
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significant shape differences between the left and right
thalamus in PD but not in controls. Significant shape dif-
ferences between PD and controls were detected in both
the left and right thalami.
For PD subjects, an ANOVA examining the influences on
the distance metric (Eqn 8) of acquisition site, side of
symptoms or duration (F(1,20) = 1.9, p = 0.18; F(1,20) =
1.59, p = 0.22; F(17,20) = 1.35, p = 0.26; respectively). As
all PD subjects were right handed, handedness could not
be tested in this group. Similarly, an ANOVA on the dis-
tance metric for all subjects examining site of acquisition
(F(1,72) = 0.14, p = 0.71) or handedness (F(1,72) = 0.16,
p = 0.69) did not find factors of significance with a fixed
effects model.
In order to better visualize and intuitively assess the shape
differences in thalami between PD subjects and controls,
we took thalami that had "typical" feature vectors (i.e. fea-
ture vectors closest to the mean of each group) and
assumed that they represented exemplar shapes. We then
spatially aligned these exemplar shapes (Figure 2). There
appeared to be greater differences in the left thalami
between controls and PD subjects. The largest differences
appeared to be along the dorsal surface. Note that the reg-
istration of the thalami in this instance was solely for vis-
ualization purposes and was not incorporated into the
analysis.
Discussion
It is well known that changes in the thalamus can be seen
chronically after cortical injury [25,26]. This is not only
due to direct effects of axonal damage, as axonal-sparing
cortical lesions also result in thalamic degeneration [27].
Such thalamic degeneration probably involves both anter-
ograde and retrograde processes [28] and may be miti-
gated by growth factors [29,30]. Brain development has a
critical role on the extent of thalamic changes after a cor-
tical lesion. Animal models have determined that perina-
tal lesions are far less likely to induce thalamic changes,
compared to when the cortical lesions are made prenatally
[31] or in adulthood [32]. In contrast to the secondary
effects of thalamic changes from cortical lesions, the tha-
lamic changes in PD are related to selective non-dopamin-
ergic neurodegeneration [1].
Consistent with prior results, we found no significant dif-
ferences in the volume of the thalami between PD subjects
and controls [3]. However, for the first time, we have dem-
onstrated that the shape of the thalami undergoes system-
atic changes in PD. The reason that shape may change but
not the volume may be due to the fact that particular
nuclei (e.g CM-Pf) are involved, and thus, at the typical
resolution of MRI, this does not result in significant
changes in the overall volume. Alternately, since thalamic
volume may actually increase as a compensatory mecha-
nism [12], other regions of the thalamus may hypertro-
phy.
The ability to non-invasively quantify subtle morphologi-
cal shape changes appears to be a powerful technique. We
utilized standard structural MR imaging techniques with-
out any special sequences nor any special scanner resolu-
tion requirements. We obtained robust results from
pooling data from two different centres using two differ-
ent types of scanners.
We used manual segmentation of the thalami in this
paper. Automatic segmentation of subcortical structures is
an area of ongoing research [33], and often requires the
tuning of many parameters, especially when the images
may be pooled from scanners from different centres. Since
the person at each centre doing the segmentation was
blinded to disease status, it would be unexpected that a
systematic bias was introduced into our results. Even then,
any misspecification of the same ROI across subjects
The SPHARM-based method for shape determinationFigure 1
The SPHARM-based method for shape determina-
tion. The shape to be specified (the thalamus) and two con-
centric spherical shells are shown. On the right is the 
intersection between the thalamus and shells as a function of 
rotation (θ) and azimuth (h). The rotation angle spans from 
0 to 2π radians, and the azimuth angle is from 0 to π radians.
Table 1: Results of volumetric and shape analysis. Numbers 
indicate the p-values obtained from the permutation test.
Group Volume SPHARM
Control, Left vs. Right 0.5630 0.1470
PD, Left vs. Right 0.5780 0.0060
Left thalamus, PD vs. Control 0.4150 0.0270
Right thalamus, PD vs. Control 0.1730 0.0290Page 3 of 8
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Two sets typical thalami registered and shown on brain from a PD subjectFigur  2
Two sets typical thalami registered and shown on brain from a PD subject. Note that the registration here is solely 
for visualization purposes, and is not required for the calculation of shape differences. Also, although the thalami here were 
first smoothed with a 12 mm FWHM Gaussian kernel for visualization purposes, no smoothing was performed for the shape 
analysis and group comparison.
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sumably reduce discriminability across groups making the
task harder for the shape analysis approach.
We used SPHARM-based invariant descriptors to quantify
the shape of the thalami. The main advantages of such a
method is that it does not require that all brain images be
warped to a common space, nor does it require that the
brain images be aligned in any way. A drawback of these
invariant features approach is that it is difficult to invert
the feature vectors, i.e. once given all the values of the dif-
ferent invariants, it is impossible to reconstruct the origi-
nal image which gave that feature vector – analogous to
the fact that given the volume of an object, it is impossible
to uniquely reconstruct the original shape. We therefore
cannot create a "typical" brain structure by averaging the
feature vectors and create the image that would give this
feature vector (e.g. to create an "average left thalamus").
However, it is possible to cluster structures in the feature
space and find the brain structure whose feature vector is
in the middle of the cluster so as to use it as an exemplar
shape, which we have done (Figure 2).
It is difficult to determine if the shape differences we
detected are attributable to any specific nuclei. However,
based on prior pathological studies, it would be likely that
the differences we detected were related to degeneration
in the CM-Pf complex. Given that progressive supranu-
clear palsy (PSP) has even greater involvement of VLp
than PD [4], it remains to be seen if thalamic shape is a
discriminable feature between these two conditions.
We did not detect any association between overall shape
change and handedness, and dominant side presentations
or presence/absence of tremor. This may be due to the rel-
atively small sample size employed in this study. How-
ever, because the feature vectors consist of many different
components, we don't discount that there may be a subset
of components that are sensitive to these disease parame-
ters.
Conclusion
Our results suggest that systematic changes in thalamic
shape can be non-invasively assessed in PD in vivo and
that shape changes, in addition to volume changes, may
represent a new avenue to assess the progress of neurode-
generative processes. Although we cannot state which
parts of the thalamus are directly affected, previous path-
ological studies would suggest that the shape changes
detected in this study represent degeneration in the centre
median-parafascicular (CM-Pf) complex, an area known
to represent selective non-dopaminergic degeneration in
PD.
Methods
The study was approved by the appropriate Institutional
Review Boards and Ethics Boards of the University of Brit-
ish Columbia (UBC) and the University of North Caro-
lina (UNC). All structural data were obtained as part of
fMRI studies whose results are reported elsewhere (e.g.,
[34]).
MR Imaging at the University of British Columbia
All subjects gave written informed consent prior to partic-
ipating. Nine volunteers with clinically diagnosed PD par-
ticipated in the study (5 men, 4 women, mean age 68.1 ±
6.8 years, 7 right-handed, 2 left-handed). All subjects had
mild to moderate PD (Hoehn and Yahr stage 2–3) [35]
with mean symptom duration of 3.6 ± 2.6 years. We
recruited ten healthy, age-matched control subjects with-
out active neurological disorders (3 men, 7 women, mean
age 55 ± 12.4 years, 9 right-handed, 1 left-handed). Exclu-
sion criteria included atypical Parkinsonism, presence of
other neurological or psychiatric conditions and use of
antidepressants, sleeping tablets, or dopamine blocking
agents.
MRI was conducted on a Philips Achieva 3.0 T scanner
(Philips, Best, The Netherlands) equipped with a 6 chan-
nel Sense head-coil. A high resolution, three dimensional
(3D) SPGR image data set of the whole brain consisting of
170 axial slices at a FOV of 256 × 200 mm2 was acquired
for WM/GM segmentation purposes and as anatomical
reference (inversion prepared 3D T1TFE, TR = 7.746 ms,
TE = 3.55 ms, inversion delay = 880 ms, flip angle = 8.00°,
voxel dimensions 1.0 × 1.0 × 1.0 mm3).
The thalami were one of eighteen specific regions of inter-
est (ROIs) that were manually drawn on each unwarped,
aligned structural scan using the Amira software (Mercury
Computer Systems, San Diego, USA). Although the tha-
lami were manually segmented on the axial slices, they
were carefully examined in the coronal and saggital planes
to ensure accuracy. The trained technician performing the
segmentation was blinded to the disease state.
MR Imaging at the University of North Carolina
All subjects gave written informed consent prior to partic-
ipating. Nine volunteers with clinically diagnosed mild to
moderate PD (Hoehn and Yahr stage 2–3 – mean symp-
tom duration of 2.1 ± 2.0 years) participated in the study
(5 men, 4 women, mean age 58 ± 12 yrs, all right-
handed). We also recruited eight healthy, age-matched
control subjects without active neurological disorders (5
men, 3 women, mean age 49 ± 14 yrs, 8 right-handed).
Images were acquired on a 3.0 Tesla Siemens scanner (Sie-
mens, Erlangen, Germany) with a birdcage-type standard
quadrature head coil and an advanced nuclear magnetic
resonance echoplanar system. The head was positionedPage 5 of 8
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limit head motion. High-resolution T1 weighted anatom-
ical images were acquired (3D SPGR, TR = 14 ms, TE = 7.7
ms, flip angle = 25°, voxel dimensions 1.0 × 1.0 × 1.0 mm,
176 × 256 voxels, 160 slices).
ROIs (including thalami) were drawn manually by the
same trained research associate with assistance from mul-
tiple on-line and published atlases (e.g. [36]).
Thalami Shape Analysis
As described in the technical appendix, the analysis of
each shape results in a unique feature vector, of length n =
1440. The left and right thalami were analyzed separately.
For comparison, we examined for any differences in vol-
ume. The volume of each thalamus was estimated as the
number of voxels that each ROI contained multiplied by
the volume of a single voxel.
To assess the significance of group differences between
feature vectors, we used a permutation test to generate a
null distribution of Euclidean distances between feature
vectors. The permutation test does not require a priori
assumptions about the data distribution, and is thus pre-
ferred over T-test and F-test [37]. We assessed the differ-
ences in left vs. right thalami in controls, left vs. right in
PD subjects, PD vs. controls for the left thalamus, and PD
vs. controls for the right thalamus. Although the bounda-
ries of the thalami were determined by visual inspection,
in prior work we compared feature vectors derived from
thalami segmented from structural scans obtained before
and after giving L-dopa medication (as part of another
fMRI study) [38]. As expected, no significant differences
could be detected in the two groups, suggesting that inde-
pendent manual segmentation did not incur significant
systematic errors.
Shape Analysis – technical aspects
Let Ψ(θ, φ) be a function defined on the unit spherewith
θ and φ as the zenithal and azimuthal angles, respectively.
The SPHARM representation for this function is given by
(1) where  is the complex conjugate of the mth
order spherical harmonic of degree l. l ranges from 0 to L
[16]. Increasing the value of L, also called the bandwidth,
improves the representation accuracy at the cost of higher
computation time. This definition can also be extended to
real valued 3D distributions Ψ(r, θ, φ) (2), where r is the
distance from the origin to a given voxel. k is an index
introduced to account for possible degeneracy due to the
additional dimension [39].
As explained later in this section, rotationally invariant
features can be derived from this spherical harmonic rep-
resentation. In our application, we also need the features
to be invariant to any translation of the entire ROI in 3D
space. To achieve this, we move the origin of the function
Ψ(r, θ, φ), to the centroid of Ψs(r, θ, φ), where Ψs(r, θ, φ)
is given by (3).
Since direct computation of (2) is highly inefficient [40],
we use an alternate approach by representing the data as a
set of spherical functions obtained by intersecting the 3D
data with spherical shells. Alternatively, for each value of
r, Ψ(r, θ, φ) can be visualized as a spherical shell compris-
ing the function values at a distance r from the origin. r
can then be incremented in steps of t to encompass the
entire ROI. If the initial representation of the function is
in the form of a cubic grid (regular isotropic voxels in our
case), volumetric interpolation is required to resample the
ROI in the spherical coordinate space.
When analyzing multiple subjects' ROIs simultaneously,
we define the maximum radius, Rmax, as the minimum
radial distance in voxel count that encompasses all non-
zero values of all subjects' ROIs being analyzed. To repre-
sent the values from the cubic grid of all ROIs with suffi-
cient accuracy, 2Rmax shells are used. To achieve scale
invariance, the shells must be distributed evenly through-
out the spatial extent of each ROI. Since the ROI size
across subjects is not uniform, shell spacing t must be
adjusted for each subject separately. This procedure
ensures that each shell captures similar features from the
3D ROI irrespective of its scale.
Surface sampling along each of these shells is performed
on an equiangular spherical grid of dimensions 2L × 2L
[40]. The common bandwidth L for all shells of all func-
tions is chosen to satisfy the sampling criterion for the
largest shell in this set of ROI, namely the one with radius
Rmax. The surface area for this shell represents the maxi-
mum surface shell area that needs to be sampled by the
equiangular grid; hence, any value of L satisfying the
Ylm
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be sufficient to represent data from smaller radii shells.
The minimum value for L is obtained by equating the sur-
face area of this largest shell to the equiangular sampling
grid (4). Higher values of L are not used, since it increase
computation time with no added benefit. Also, this will
result in longer feature vectors, complicating the analysis.
Furthermore, when the represented object is a discrete
array, higher values of l, resulting from a larger L, may cor-
respond to sampling noise [39]. Recognizing that in
applications pertaining to discrimination, high accuracy
in the SPHARM representation is not a necessity, we chose
to use the minimum value for L as that obtained by (4).
To obtain the SPHARM representation for all shells, a dis-
crete SPHARM transform is performed at each value of r to
obtain  (5). Features derived from this representation,
however, do not provide a unique function representation
[41,42]. For instance, rotating the inner and outer shells
by different amount will result in different spatial distri-
bution of function values. However, in this approach, the
derived features are insensitive to these rotational trans-
forms, thus resulting in the same feature values for dissim-
ilar spatial distributions.
Burel and Henocq's original equation (2) does not have
this problem, since a part of the basis function is a func-
tion of r. However, since (2) is computationally intracta-
ble [17], we proposed an efficient approach that uses a
radial transform (6), derived from (2), to obtain a unique
function representation. The transform (6) retains the rel-
ative orientation information of the shells, thus the fea-
tures derived will be sensitive to independent rotations of
the different shells, thereby ensuring that unique feature
representation is obtained.
The range of k could be changed to obtain different
lengths of the final feature vector. However, to avoid
unnecessarily increasing the feature vector length or los-
ing any important information caused by reducing the
range, we choose to keep the range of k the same as that
of r, i.e. 2Rmax.
From the obtained representation (6), we then compute
similarity transform invariant features using (7) for each
value of l and k [39] with p and q are used to index these
features. Note we reshape I into a single row vector of
dimensions D = L × 2Rmax for later analysis.
In order to provide a scalar estimate how different a given
thalamus shape was, we calculated the mean of the row
vectors, I (Eqn 7) separately for both the left and right tha-
lami. A distance metric, estimating how "abnormal" a
given shape was estimated by determining the Euclidean
distance between the given feature vector and the mean
vector. For example, the distance for right thalamus for the
jth subject was estimated as:
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